Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
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
SPd2kDEa5uQgGzCD
